Analysis Level of Serum Estradiol Hormone of Pregnant Women with Melasma
American Journal of Clinical and Experimental Medicine
Volume 4, Issue 2, March 2016, Pages: 26-29
Received: Feb. 15, 2016; Accepted: Feb. 29, 2016; Published: Mar. 21, 2016
Views 3589      Downloads 69
Authors
Andi Miranti, Department of Dermatology, Medical Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
Anis Irawan Anwar, Department of Dermatology, Medical Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
Khairuddin Djawad, Department of Dermatology, Medical Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
Ilhamjaya Patellongi, Faculty of Public Health, Hasanuddin University, Makassar, South Sulawesi, Indonesia
Siswanto Wahab, Department of Dermatology, Medical Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
Nusratuddin Abdullah, Department of Obstetric and Ginecology, Medical Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
Article Tools
Follow on us
Abstract
Hormonal changes in pregnancy are the important etiology of melasma. The presence of melasma in more than 75% of pregnancies. At the end of pregnancy, estrogen levels increase. Estrogen, especially estradiol triggers increased synthesis of melanin. This paper is aimed to determine the relationship between estradiol hormone with melasma and the type ofmelasma in pregnant women. This study used a cross-sectional study design to determine the relationship of estradiol hormone with melasma. It was conducted from September-November 2015. Skin examination was performed on 64 pregnant women (15-49 years old) who suffered from melasma in the third trimester and who did not, and the blood was drawn to measure the level of serum estradiol hormone. The study results that the levels of estradiol was slightly higher in women with melasma than those without melasma (13811.7 vs 12820.5), but not statistically significant (p>0.05). There was slightly higher levels of estradiol in women with the mixed type of melasma than the other types (14444.10 vs 14047.25 and 12243.50), but it was not statistically significant (p>0.05). Estradiol levels correlated significantly (p<0.05) with maternal age (r = 0.238) and gestational age (r = 0.435); but did not correlate significantly (p>0.05) with MASI (Melasma Area Severity Index) score and the type of melasma. The study concluded that estradiol levels in women with melasma are higher than not melasma and in mothers with type mix melasma were higher than other types, but not statistically significant. Estradiol level correlated with maternal age and gestational age.
Keywords
Estradiol, Melasma, Pregnant
To cite this article
Andi Miranti, Anis Irawan Anwar, Khairuddin Djawad, Ilhamjaya Patellongi, Siswanto Wahab, Nusratuddin Abdullah, Analysis Level of Serum Estradiol Hormone of Pregnant Women with Melasma, American Journal of Clinical and Experimental Medicine. Vol. 4, No. 2, 2016, pp. 26-29. doi: 10.11648/j.ajcem.20160402.13
Copyright
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Sarkar, R., Arora, P., Garg, V. K., Sonthalia, S., Gokhale, N. 2014. Melasma update. Indian Dermatology Online Journal. 5: 426-435.
[2]
Sardesai, V. R., Kolte, J. N., Srinivas, B. N. 2013. A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment.Indian J Dermatol. 58: 1-5.
[3]
Akram, S., Sattar, F., Tahir, R., Mujtaba, G. 2013. Efficacy of topical 4% liquiritin compared with topical 4% liquiritincampuran in 5% ascorbic acid in the treatment of melasma. Journal of Pakistan Association of Dermatologists. 2: 149-152.
[4]
Sarkar, R., Arora, P., Garg, V. K., Sonthalia, S., Gokhale, N. 2014. Melasma update. Indian Dermatology Online Journal. 5: 426-435.
[5]
Handel, A. C., Miot, L. D. B. Miot, H. A., 2014. Melasma: a clinical and epidemiological review. An Bras Dermatol. 5: 771-782.
[6]
Jadotte, Y. T., Schwartz, R. A. 2010. Melasma: Insight and Perspectives. Acta Dermatovenerol Croat. 2: 124-129.
[7]
Moin, A., Jabery Z., Fallah N. 2006. Prevalence and awareness of melasma during pregnancy. International Journal of Dermatology. 45: 285-288.
[8]
Rakhmawati, D. 2013. Pengaruh Kadar Estradiol Basal terhadap Melasma. Tesis tidak diterbitkan. Yogyakarta: Fakultas Kedokteran - Universitas Gadjah Mada.
[9]
Wiedemann, C., Nagele, U., Schramm, G., Berking, C. 2009. Inhibitory effects of progesterons on the estrogen stimulation of melanocytes in vitro. Contraception. 80: 292-298.
[10]
Cestari, T. F., Andrade, C. B. 2005. Hyperpigmentation and Melasma: A physiopathologic review for the clinical dermatologist. Cosmetic Dermatology. 10: 703-706.
[11]
Im, S., Lee, E-S., Kim, W., On, W., Kim, J., Lee, M., Kang, W.H. 2002. Donor Specific Response of Estrogen and Progesterone on Cultured Human Melanocytes. J Korean Med Sci. 17: 58-64.
[12]
Costin, G. E., Birlea, S. A. 2006. What is the mechanism for melasma that so commonly accompanies human pregnancy? IUBMB life. 52(1): 55-57.
[13]
Anwar, R. 2005. Endokrinologi Kehamilandan Persalinan. Bandung: Fakultas Kedokteran UNPAD.
[14]
Thornton, M. J. 2002. Experimental Dermatology. 11: 487-502.
[15]
Damevska, K. 2014. New Aspects of Melasma. Serbian Journal of Dermatology and Venereology. 6(1): 5-18.
[16]
Stulberg, D. L., Clark, N., Tovey, D. 2003. Common Hyperpigmentation Disorders in Adults: Part II. Melanoma, Seborrheic Keratoses, Acanthosis Nigricans, Melasma, Diabetic Dermopathy, Tinea Versicolor, and Postinflammatory Hyperpigmentation. Am Fam Physician. 68: 1963-8.
[17]
Doria, A., Iaccarino, L., Sarzi-Puttini, P., Ghirardello, A., Zampieri, S., Arienti, S., Cutolo, M., Todesco, S. 2006. Estrogens in Pregnancy and Systemic Lupus Erythematosus. Annals New York Academy of Sciences. 1069: 247-256.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186